Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ TTR Monoclonal Antibody (2E10C5)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA1221
Description
MA1-221 detects Transthyretin protein in ELISA and Western Blot applications. The MA1-221 immunogen is the purified recombinant fragment of human TTR (AA: 1-147) expressed in E. Coli.
Transthyretin (TTR), generally called prealbumin, is a plasma protein that plays an important role in physiology such as a transporter of hormone thyroxine and retinal-binding protein. After produced primarily in the liver, TTR is excreted into the plasma. TTR represents a disproportionate fraction (25%) of CSF protein, prompting the suggestion that it is either selectively transported across the blood-CSF barrier or synthesized de novo within the central nervous system. Transthyretin is a constituent found to the neuritic plaques, neurofibrillary tangles, and microangiopathic lesions of senile cerebral amyloid. It has been reported that more than 40 different mutations in the TTR gene associated with amyloid deposition.
Specifications
TTR | |
Monoclonal | |
1 mg/mL | |
PBS with 0.05% sodium azide | |
P02766 | |
TTR | |
Purified recombinant fragment of human TTR (AA: 1-147) expressed in E. Coli. | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG1 |
ELISA, Western Blot | |
2E10C5 | |
Unconjugated | |
TTR | |
AA408768; AI787086; Amyloidosis I; ATTR; carpal tunnel syndrome 1; CTS; CTS1; D17860; epididymis luminal protein 111; HEL111; HsT2651; Lr1; PALB; prealbumin; pre-albumin; prealbumin, amyloidosis type I; Tbpa; thyroxine-binding prealbumin; transthyretin; Tt; TTR | |
Mouse | |
Protein A | |
RUO | |
7276 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction